Clinical Trials
- Brain, Spinal Cord & Nervous System
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Immunologic Mechanisms in Neurological Diseases
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Myasthenia Gravis Inebilizumab Trial (MINT)
- Ages18 years and older
- GenderBoth
- Orthopaedics, Muscle & Bone
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE-XT)
- Ages40 years - 80 years
- GenderBoth
- Orthopaedics, Muscle & Bone, Brain, Spinal Cord & Nervous System
Registry of Patients With Generalized Myasthenia Gravis Who Have Ever Been Treated With C5 Inhibition Therapies